Jeff Inglis's clip file

Published in Drug Discovery News WASHINGTON, D.C.—Hoping to expand both statistical validity of clinical trials and access to experimenta...

Published in Drug Discovery News NEW YORK—Two separate HIV therapies manufactured by  Merck , one new and the other a groundbreaking favor...

Published in Drug Discovery News LA JOLLA, Calif.— Scripps Research Institute  scientists have devised two highly specific methods to crea...

Published in Drug Discovery News SUNNYVALE, Calif.—Building quickly on the November 2013 approval of its first drug to market,  Pharmacyc...

Published in Drug Discovery News SOUTH SAN FRANCISCO, Calif.—Seeking to continue, and accelerate, its work developing new protein therape...

Published in Drug Discovery News LONDON—Taking a lead in the tight race to develop and release melanoma medications, GlaxoSmithKline plc (...

Published in Drug Discovery News BOSTON—Taking protein-growing to high altitude and low gravity,  Emerald Bio  has joined an arrangement l...

Published in Drug Discovery News SAN DIEGO—Expanding applications of its recently FDA-approved MiSeqDx  in-vitro diagnostic next-generatio...

Published in Drug Discovery News THOUSAND OAKS, Calif.—Completing a key step toward filing for regulatory approval of a broadly applicable...

Published in Drug Discovery News BRISBANE, Australia—After a decades-long search for a so-called “holy grail” of biochemistry, Australian...

Published in Drug Discovery News DUBLIN—Rapidly expanding its orphan-drug portfolio and planning for $1 billion in revenue in 2014, Irish...

Published in Drug Discovery News MUNICH, Germany—Seeking to commercialize a genetic diagnostic test that can reduce the incidence of suici...